Europe
Motif Bio plc announced the appointment of Andrew Powell, J.D. as Non-executive Director, effective immediately.
Karolinska Development AB announces that The Board of Directors has decided to delay the publication of its Annual Report for 2018.
As a monotherapy, Keytruda showed non-inferiority to standard of care but missed the mark as a combination treatment.
AstraZeneca reported first-quarter financials, with Product Sales growing 10% (14% at CER) to $5.465 billion. What is more startling, and completely in accordance with the company’s stated goals, Global Oncology sales increased by 54%.
This is the second extension that has been filed, this time delaying it until June 3. The companies indicate it is because U.S. authorities are taking longer than expected to review the deal.
Galapagos NV presents financial results and highlights the key events for the first quarter of 2019.
DCprime announced the appointment of two highly-experienced industry veterans, Andrea van Elsas, Ph.D. and Hans Preusting, Ph.D., M.B.A, to its Supervisory Board.
Aqilion searches for early innovative pharmaceutical projects that are based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit.
Young Entrepreneur Council is an invitation-only community for the world’s most successful entrepreneurs.
At the Annual General Meeting of Immunicum AB (publ), reg. no 556629-1786, on April 25, 2019 the AGM adopted, inter alia, the following resolutions.
PRESS RELEASES